PROton therapy for HPV-related oroPHaryngeal cancer patients using normal tissue complication probability (NTCP) modEl-based strategy: an iTalian multIcenter retrospective Cross-sectional study - PROPHETIC.
Abstract
Background
Intensity-modulated proton therapy (IMPT) has shown promise in reducing toxicityfor patients with oropharyngeal squamous cell carcinoma (OPSCC), while maintaining comparable tumor control to intensity-modulated radiation therapy (IMRT). However, technical, logistical and economic factors have limited widespread implementation.
Methods
We conducted the first Italian multicenter in-silico comparative study of photon and proton plans in 100 patients with HPV-related OPSCC, involving seven radiation oncology departments. Clinical photon-based plans (mostly using Volumetric Modulated Arc Therapy (VMAT)) were compared with robustly optimized IMPT plans generated using the CNAO beamline. Dosimetric endpoints and normal tissue complication probability (NTCP) values for xerostomia and dysphagia were assessed. Eligibility for IMPT was retrospectively estimated using the Dutch model-based selection (MBS)criteria.
Results
Target coverage was comparable between modalities, although IMPT plans showed slightly lower conformity indices. IMPT significantly reduced the dose bath to healthy tissues, with lower mean doses to the parotids, submandibular glands, pharyngeal constrictors, oral cavity, brainstem, and spinal cord (p < 0.01). NTCP analyses predicted clinically relevant reductions in xerostomia and dysphagia with IMPT. Applying the MBS approach, 36 % of patients were deemed eligible for PT, consistent with previous reports. Inter-center variability in eligibility reflected differences in delineation practices and clinical protocols.
Conclusions
This study tested the feasibility of a multicenter model-based evaluation for IMPT in Italy. A substantial proportion of OPSCC patients could benefit from IMPT, though results likely represent a conservative estimate due to protocol choices. Standardized delineation, robust optimization, and integration of NTCP models are essential for consistent patient selection.